Halozyme Therapeutics, Inc. (HALO)

70.43 -0.78 (-1.10%) USD  |  NASDAQ  |  Jan 20, 16:00
70.25 -0.18 (-0.26%) Pre-Market: 08:35
More

Halozyme Therapeutics Preferred Stock Dividend (Quarterly)

Preferred Stock Dividend (Quarterly) Chart

View Preferred Stock Dividend (Quarterly) for HALO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Preferred Stock Dividend (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Preferred Stock Dividend (Quarterly) Range, Past 5 Years

View Preferred Stock Dividend (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Preferred Stock Dividend (Quarterly) Benchmarks

View Preferred Stock Dividend (Quarterly) Benchmarks
Start Trial
Johnson & Johnson Upgrade
Merck & Co., Inc. Upgrade
AIM ImmunoTech, Inc. Upgrade
Stryker Corp. Upgrade
Skye Bioscience, Inc. Upgrade